위식도역류질환에 대한 반하후박탕의 효과 : 체계적 문헌고찰과 메타분석
Effects of Banhahubak-tang on Gastroesophageal Reflux Disease : A Systematic Review and Meta-Analysis
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives : This study was designed to investigate the effect of Banhahubak-tang on gastroesophageal reflux disease(GERD) through a systematic review and meta-analysis of randomized controlled trials(RCTs). Methods : RCTs using Banhahubak-tang on GERD was searched in databases such as EMBASE, PubMed, MEDLINE, CENTRAL, CNKI, KISS, RISS, ScienceON, and OASIS. RCTs published up to October 8th, 2021 were included. Meta-analysis was performed by synthesizing outcome data, including Total Effectiveness Rate (TER), Reflux Symptom Index(RSI), Reflux Finding Score(RFS), and Incidence of Adverse Reactions. RevMan 5.4 software was used for data analysis. The Cochrane collaboration bias risk assessment scale was used to evaluate the methodological quality of the included studies. Results : Ten RCTs met the inclusion criteria. The total effective rate was the most commonly used outcome measure. The meta-analysis revealed that the TER in the experimental group was higher than that of the control group(N=2, RR:1.22, 95% CI:1.09 to 1.36, P=0.0004, I²=0%)(N=6, RR:1.22, 95% CI:1.14 to 1.32, P‹ 0.00001, I²=0%)(N=8, RR:1.22, 95% CI: 1.14 to 1.30, P‹0.00001, I²=0%). On the other hand, RSI(N=2, MD : -4.29, 95% CI: -4.71 to –3.86, I²=94%), RFS(N=2, MD : -3.28, 95% CI: -3.71 to –2.85, I²=96%), and Incidence of Adverse Reactions(N=5, RR: 0.32, 95% CI: 0.17 to 0.61, I²=0%) in the experimental group were lower than that of the control group. Conclusion : Treatment with Banhahubak-tang was found to be effective on GERD. However the results might be biased because of the poor quality and small sample size of the included RCTs.
Abstract
Objectives : This study was designed to investigate the effect of Banhahubak-tang on gastroesophageal reflux disease(GERD) through a systematic review and meta-analysis of randomized controlled trials(RCTs). Methods : RCTs using Banhahubak-tang on GERD was searched in databases such as EMBASE, PubMed, MEDLINE, CENTRAL, CNKI, KISS, RISS, ScienceON, and OASIS. RCTs published up to October 8th, 2021 were included. Meta-analysis was performed by synthesizing outcome data, including Total Effectiveness Rate (TER), Reflux Symptom Index(RSI), Reflux Finding Score(RFS), and Incidence of Adverse Reactions. RevMan 5.4 software was used for data analysis. The Cochrane collaboration bias risk assessment scale was used to evaluate the methodological quality of the included studies. Results : Ten RCTs met the inclusion criteria. The total effective rate was the most commonly used outcome measure. The meta-analysis revealed that the TER in the experimental group was higher than that of the control group(N=2, RR:1.22, 95% CI:1.09 to 1.36, P=0.0004, I²=0%)(N=6, RR:1.22, 95% CI:1.14 to 1.32, P‹ 0.00001, I²=0%)(N=8, RR:1.22, 95% CI: 1.14 to 1.30, P‹0.00001, I²=0%). On the other hand, RSI(N=2, MD : -4.29, 95% CI: -4.71 to –3.86, I²=94%), RFS(N=2, MD : -3.28, 95% CI: -3.71 to –2.85, I²=96%), and Incidence of Adverse Reactions(N=5, RR: 0.32, 95% CI: 0.17 to 0.61, I²=0%) in the experimental group were lower than that of the control group. Conclusion : Treatment with Banhahubak-tang was found to be effective on GERD. However the results might be biased because of the poor quality and small sample size of the included RCTs.
참고문헌 (33)
- Vakil N, "The Montreal definition and classification of gastroesophageal reflux disease : a global evidencebased consensus", Am J Gastroenterol, 101, pp.1900~1920 (2006)
- Son YW, "Clinical Trial Guidelines for Gastroesophageal Reflux Disease Treatment", ~ (2015)
- 양선영, "위식도역류질환 환자의 식이 위험요인 및 삶의 질", 대한내과학회지, 70(6), pp.627~635 (2006), 대한내과학회
- 남승주, "위식도역류 질환의 식도 외 증상", 대한내과학회지, 91(3), pp.257~263 (2016), 대한내과학회[DOI]
- "National Health Insurance Statistical (2020)" (2020)[URL]
- Department of Internal Medicine, National College of Oriental Medicine, "Internal Medicine", pp.314~318 (2008), Gunja Publishing House
- 윤상협, "위 운동성 장애가 동반된 역류성 식도염 환자에 대한 한방단독 치험 1례", 대한한방내과학회지, 37(4), pp.669~677 (2016), 대한한방내과학회
- 김윤희, "熱多寒少湯으로 호전된 역류성 식도염 환자 1례", 사상체질의학회지, 23(1), pp.132~138 (2011), 사상체질의학회
- 이재은, "식도열공탈장을 동반한 위식도 역류성 질환 환자 치험 1례", 대한한방내과학회지, 26(1), pp.1~17 (2005), 대한한방내과학회
- 임태형, "소양인 망음증으로 진단한 역류성식도염 치험 2례", 사상체질의학회지, 27(2), pp.297~306 (2015), 사상체질의학회[DOI]
- 정유진, "중국 및 한국 Database에서의 위식도 역류질환에 대한 반하사심탕의 효과에 대한 최근 10년간의 연구경향", 대한한방내과학회지, 41(3), pp.362~413 (2020), 대한한방내과학회[DOI]
- 김근홍, "역류성 식도염에서의 二陳湯加味方의 효과에 대한 문헌적 고찰", 한의학연구소 논문집, 22(1), pp.119~128 (2013), 한의학연구소
- 최가영, "역류성 식도염의 변증과 처방에 관한 문헌적 고찰 - 중국 논문 중심으로 -", 대한한방내과학회지, 32(1), pp.75~86 (2011), 대한한방내과학회
- College of Oriental Medicine Professor of The Herbal Formula Science, "The Herbal Formula Science", pp.382~383 (2006), Yeongnimsa
- Lee DG., "Geumgweyolyag", pp.292~293 (2002), Seowondang
- College of Oriental Medicine Professor of The Herbal Formula Science, "The Herbal Formula Science", pp.893~901 (2020), Gunja Publishing House
- "ChapterS:assising risk of bias in included studies, In Chochrane hand book for systematic rivies of interventions version5.1.0" (2011)[URL]
- 이준영, "메타분석", Endocrinology and Metabolism, 23(6), pp.361~378 (2008), 대한내분비학회
- Bian YY, "Clinical Study of Banxia Houpu Decoction Combined with Rabeprazole in the Treatment of Reflux Esophagitis", Journal of New Chinese Medicine, 53(14), pp.18~21 (2021)
- Chen X, "Clinical observation of modified Banxia Houpu decoction combined with oral esmprazole in the treatment of erosive esophagitis", Contemporary Medicine, 25(25), pp.155~156 (2019)
- Lai XL, "Clinical efficacy of Banxia Houpu decoction combined with rabeprazole in the treatment of reflux esophagitis in the elderly", Strait Pharmaceutical Journal, 31(6), pp.147~148 (2019)
- Cai S, "Clinical observation of Banxia Houpu decoction combined with western medicine in the treatment of reflux esophagitis", Chinese Medicine Modern Distance Education of China, 17(10), pp.112~114 (2019)
- Zhang XH, "Clinical observation of Banxia Houpu Decoction in the treatment of pharyngeal and laryngeal reflux diseases", Clinical Journal of Chinese Medicine, 11(8), pp.50~52 (2019)
- Feng SB, "Clinical observation of Banxia Houpu decoction combined with acid drugs in the treatment of reflux pharyngitis", Clinical Journal of Chinese Medicine, 10(28), pp.85~86 (2018)
- Huang TW, "Effect of modified Banxia Houpu Decoction on refractory gastroesophageal reflux disease", Journal of Practical Medical Techniques, 25(6), pp.625~626 (2018)
- Wang LB, "Clinical observation on 40 cases of reflux esophagitis with qi stagnation and phlegm obstruction treated with integrated traditional Chinese and Western Medicine", Chinese Journal of Ethnomedicine and Ethnopharmacy, 27(9), pp.98~ (2018)
- Zhao DM, "Significance of PPARγ, HIF-1α in reflux esophagitis and the intervention of Banxiahoupo Decoction", Chinese Journal of integrated traditional Chinese and Western medicine digestion, 23(11), pp.783~786 (2015)
- Feng YH, "Effect of modified Banxia Houpu Decoction on reflux esophagitis", Chinese Medicine Modern Distance Education of China, 12(23), pp.141~143 (2014)
- 정혜경, "위식도역류질환 임상진료지침 개정안 2012", 대한소화기학회지, 60(4), pp.195~218 (2012), 대한소화기학회
- Hunt R, "World gastroenterology organisation global guidelines : GERD global perspective on gastroesophageal reflux disease", J Clin Gastroenterol, 51(6), pp.467~478 (2017)
- 박찬혁, "위식도역류질환", 대한소화기학회지, 73(2), pp.70~76 (2019), 대한소화기학회
- Kim JR, "Kim’s Digestive Diseases", pp.158~170 (2008), Ilchokak
- College of Oriental Medicine Professor of The Herbology, "The Herbology", pp.156~157 (2020), Yeongnimsa